உலகளாவிய உரிமையாளர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய உரிமையாளர்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய உரிமையாளர்கள் Today - Breaking & Trending Today

Riding Momentum of Robust 2020 Sales, Chem-Dry Aims to Add 75 Franchises to Flourishing Network by End of Year


Share this article
Share this article
NASHVILLE, Tenn., March 17, 2021 /PRNewswire/  As the safety of homes and workplaces remains a top priority amid the pandemic, demand for property cleaning and restoration continues to surge, as evidenced by Entrepreneur Magazine naming the industry one of the hottest franchise categories in 2021. Industry leader Chem-Dry has experienced this demand first-hand as the brand enjoys its 33
rd consecutive year as the number one-ranked carpet cleaning franchise by the magazine. With some franchise owners reporting double digit increases in consumer leads year-over-year, the growing demand led the brand to close out a very successful 2020 – which included signing over 80 franchises – positioning the market leader for another strong year. ....

United States , Ted Quinlan , Liz Robinson , Indoor Air Quality Association , Franchise Group , Healthy Home Authority , Entrepreneur Magazine , North American , Micropro Shield , Chem Dry Hot Carbonating Extraction , Hot Carbonating Extraction , Top Home Based Franchises , Global Franchises , Fishman Public Relations , Chem Dry , ஒன்றுபட்டது மாநிலங்களில் , எட் குயின்லன் , லிஸ் ராபின்சன் , உட்புற அேக தரம் சங்கம் , உரிமையை குழு , ஆரோக்கியமான வீடு அதிகாரம் , தொழில்முனைவோர் பத்திரிகை , வடக்கு அமெரிக்கன் , மேல் வீடு அடிப்படையிலானது உரிமையாளர்கள் , உலகளாவிய உரிமையாளர்கள் , மீன் பொது உறவுகள் ,

Ipsen Receives Positive CHMP Opinion Recommending Cabometyx in Combination With Opdivo as First-line Treatment for Patients Living With Advanced Renal Cell Carcinoma


Ipsen Receives Positive CHMP Opinion Recommending Cabometyx in Combination With Opdivo as First-line Treatment for Patients Living With Advanced Renal Cell Carcinoma
1
1
Patients treated with Cabometyx in combination with Opdivo reported significantly better health-related quality of life and a lower rate of discontinuation versus sunitinib
2,3
Regulatory News:
Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval for Cabometyx
(cabozantinib) in combination with Bristol Myers Squibb s Opdivo
(nivolumab) for the first-line treatment of advanced renal cell carcinoma (aRCC). The European Commission, which has the authority to approve medicines for the European Union (E.U.), will now review the CHMP recommendation and a final decision on the application in the E.U. is expected in the coming months. ....

France General , United States , Hong Kong , United Kingdom , New Zealand , South Korea , United Arab Emirates , Comunidad Autonoma De Cataluna , Dominican Republic , Saudi Arabia , Russian Federation , Cristina Su , Giovanni Asta , Bristol Myers Squibb Opdivo , Howard Mayer , Ipsen Euronext , Head Of Research , American Society Of Clinical Oncology , Bristol Myers Squibb Company , Takeda Pharmaceutical Company , Exelixis Inc , European Union , Virtual Congress , Bristol Myers Squibb , Committee For Medicinal Products Human Use , American Cancer Society ,

Merck KGaA, Darmstadt, Germany, Announces Leadership Change for North America and Global Innovative Medicine Franchises in Healthcare


Merck KGaA, Darmstadt, Germany, Announces Leadership Change for North America and Global Innovative Medicine Franchises in Healthcare
News provided by
Share this article
Share this article
DARMSTADT, Germany, Feb. 4, 2021 /PRNewswire/  Merck KGaA, Darmstadt, Germany, which operates its Healthcare business sector as EMD Serono in the US and Canada, today announced that Rehan Verjee has made the decision to leave his position as President of EMD Serono and Global Head of Innovative Medicine Franchises, to pursue an opportunity outside of the Company that will soon be announced.  He will be succeeded by Andrew Paterson, who is currently Senior Vice President and Head of both the Global Multiple Sclerosis (MS) Franchise and the MS business unit in the United States. ....

United States , Merck Kga , Peter Guenter , Rehan Verjee , Andrew Paterson , Healthcare Executive Committee , Merck Kgaa , Group Website , Global Head , Innovative Medicine Franchises , Senior Vice President , Global Multiple Sclerosis , Healthcare Executive , Executive Board , Innovative Medicines , North American , Global Franchises , Global Neurology , Immunology Franchise , ஒன்றுபட்டது மாநிலங்களில் , மெர்க் க்க , ஆண்ட்ரூ பேட்டர்சன் , சுகாதாரம் நிர்வாகி குழு , குழு இணையதளம் , உலகளாவிய தலை , புதுமையானது மருந்து உரிமையாளர்கள் ,